Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Sven Saussez and Jerome Lechien.
Connection Strength

48.657
  1. COVID-19: Post-vaccine Smell and Taste Disorders: Report of 6 Cases. Ear Nose Throat J. 2021 Sep 01; 1455613211033125.
    View in: PubMed
    Score: 0.965
  2. Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants. Lancet Infect Dis. 2022 01; 22(1):2-3.
    View in: PubMed
    Score: 0.964
  3. Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2861.
    View in: PubMed
    Score: 0.959
  4. Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19. J Intern Med. 2021 08; 290(2):468-469.
    View in: PubMed
    Score: 0.950
  5. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021 Jun 04; 10(6).
    View in: PubMed
    Score: 0.949
  6. The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated. Am J Otolaryngol. 2021 Jul-Aug; 42(4):103008.
    View in: PubMed
    Score: 0.936
  7. Clinical features of patients who had two COVID-19 episodes: a European multicentre case series. J Intern Med. 2021 Aug; 290(2):421-429.
    View in: PubMed
    Score: 0.934
  8. Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19. J Intern Med. 2021 08; 290(2):464-465.
    View in: PubMed
    Score: 0.930
  9. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2851-2859.
    View in: PubMed
    Score: 0.924
  10. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021 Aug; 290(2):451-461.
    View in: PubMed
    Score: 0.922
  11. Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne). 2020; 7:582802.
    View in: PubMed
    Score: 0.915
  12. ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review. Head Neck Pathol. 2021 Mar; 15(1):225-235.
    View in: PubMed
    Score: 0.898
  13. Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report. Laryngoscope. 2020 11; 130(11):2526-2531.
    View in: PubMed
    Score: 0.897
  14. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance. Rhinology. 2020 Aug 01; 58(4):402-403.
    View in: PubMed
    Score: 0.895
  15. Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients. Pathogens. 2020 Jul 31; 9(8).
    View in: PubMed
    Score: 0.895
  16. In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 09; 130(9):E504-E505.
    View in: PubMed
    Score: 0.890
  17. Gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol. 2020 08; 277(8):2397-2398.
    View in: PubMed
    Score: 0.889
  18. Letter to the Editor about the Beltrán-Corbellini et al. publication: 'Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study' (Eur J Neurol 2020. doi: 10.1111/ene.14273). Eur J Neurol. 2020 09; 27(9):e33.
    View in: PubMed
    Score: 0.888
  19. The association between laryngopharyngeal reflux and COVID-19 is still not demonstrated. J Med Virol. 2020 11; 92(11):2392-2393.
    View in: PubMed
    Score: 0.886
  20. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia. J Voice. 2020 Jun 04.
    View in: PubMed
    Score: 0.885
  21. Patient-Reported Outcome Questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol. 2020 08; 277(8):2393-2394.
    View in: PubMed
    Score: 0.885
  22. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study. Ear Nose Throat J. 2020 Nov; 99(9):579-583.
    View in: PubMed
    Score: 0.884
  23. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann Intern Med. 2020 10 20; 173(8):672-675.
    View in: PubMed
    Score: 0.884
  24. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool. Ear Nose Throat J. 2020 Nov; 99(9):577-578.
    View in: PubMed
    Score: 0.883
  25. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. 2020 Jul; 42(7):1583-1590.
    View in: PubMed
    Score: 0.883
  26. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug; 277(8):2251-2261.
    View in: PubMed
    Score: 0.876
  27. Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases. 2019 Oct 06; 7(19):2995-3011.
    View in: PubMed
    Score: 0.846
  28. Clinical and Acoustical Voice Quality Evolutions Throughout Empirical Treatment for Laryngopharyngeal Reflux Disease According to Gender: A Preliminary Study. Folia Phoniatr Logop. 2020; 72(4):257-266.
    View in: PubMed
    Score: 0.825
  29. Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: Our experience on 65 patients. Clin Otolaryngol. 2019 05; 44(3):379-384.
    View in: PubMed
    Score: 0.804
  30. Laryngopharyngeal reflux and benign lesions of the vocal folds. Eur Arch Otorhinolaryngol. 2019 Jan; 276(1):277-278.
    View in: PubMed
    Score: 0.796
  31. Instruments evaluating the clinical findings of laryngopharyngeal reflux: A systematic review. Laryngoscope. 2019 03; 129(3):720-736.
    View in: PubMed
    Score: 0.789
  32. The Effect of the Speech Task Characteristics on Perceptual Judgment of Mild to Moderate Dysphonia: A Methodological Study. Folia Phoniatr Logop. 2018; 70(3-4):156-164.
    View in: PubMed
    Score: 0.783
  33. The development of new clinical instruments in laryngopharyngeal reflux disease: The international project of young otolaryngologists of the International Federation of Oto-rhino-laryngological Societies. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Sep; 135(5S):S85-S91.
    View in: PubMed
    Score: 0.783
  34. Total Pharyngo-esophageal Stenosis: A New Surgical Procedure Using Modified Retrograde Transillumination Approach. Surg Laparosc Endosc Percutan Tech. 2018 Aug; 28(4):e75-e77.
    View in: PubMed
    Score: 0.779
  35. Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients. J Voice. 2019 Nov; 33(6):929-939.
    View in: PubMed
    Score: 0.779
  36. Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease. Clin Otolaryngol. 2018 10; 43(5):1273-1282.
    View in: PubMed
    Score: 0.771
  37. In response to Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease. Laryngoscope. 2018 10; 128(10):E349-E350.
    View in: PubMed
    Score: 0.761
  38. Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study. Eur Arch Otorhinolaryngol. 2018 Jun; 275(6):1513-1524.
    View in: PubMed
    Score: 0.761
  39. Voice quality outcomes of idiopathic Parkinson's disease medical treatment: A systematic review. Clin Otolaryngol. 2018 06; 43(3):882-903.
    View in: PubMed
    Score: 0.759
  40. Image analysis of the interarytenoid area to detect laryngopharyngeal reflux disease. Am J Otolaryngol. 2018 Mar - Apr; 39(2):228-229.
    View in: PubMed
    Score: 0.749
  41. Contact allergy to benzalkonium chloride in patients using a steroid nasal spray: A report of 3 cases. Ear Nose Throat J. 2018 Jan-Feb; 97(1-2):E20-E22.
    View in: PubMed
    Score: 0.749
  42. Reply to the letter "Laryngopharyngeal reflux disease in the elderly". Eur Arch Otorhinolaryngol. 2018 01; 275(1):317-318.
    View in: PubMed
    Score: 0.745
  43. Acrokeratosis paraneoplastica (Bazex syndrome). Ear Nose Throat J. 2017 Oct-Nov; 96(10-11):413-414.
    View in: PubMed
    Score: 0.736
  44. Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study. Eur Arch Otorhinolaryngol. 2017 Oct; 274(10):3687-3696.
    View in: PubMed
    Score: 0.725
  45. Impact of Chemoradiation After Supra- or Infrahyoid Cancer on Aerodynamic, Subjective, and Objective Voice Assessments: A Multicenter Prospective Study. J Voice. 2018 Mar; 32(2):257.e11-257.e19.
    View in: PubMed
    Score: 0.717
  46. Unusual presentation of an adult pedunculated hemangioma of the oropharynx. Clin Case Rep. 2017 04; 5(4):491-496.
    View in: PubMed
    Score: 0.707
  47. Unusual case of chronic maxillary rhinosinusitis. Ear Nose Throat J. 2017 Mar; 96(3):100-104.
    View in: PubMed
    Score: 0.706
  48. Validity and Reliability of a French Version of Reflux Symptom Index. J Voice. 2017 Jul; 31(4):512.e1-512.e7.
    View in: PubMed
    Score: 0.699
  49. Giant metastasis invading pharyngeal wall, pterygo­maxillary space, submaxillary and parotid glands. Rev Laryngol Otol Rhinol (Bord). 2015; 136(4):167-8.
    View in: PubMed
    Score: 0.608
  50. The study of recovery rates of COVID-19 olfactory and gustatory dysfunctions requires psychophysical evaluations. Am J Otolaryngol. 2021 Nov-Dec; 42(6):103168.
    View in: PubMed
    Score: 0.240
  51. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol. 2021 11; 28(11):3702-3711.
    View in: PubMed
    Score: 0.239
  52. Making scents of loss of taste in COVID-19: Is self-reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing. Int Forum Allergy Rhinol. 2021 10; 11(10):1504-1507.
    View in: PubMed
    Score: 0.237
  53. Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load? Am J Otolaryngol. 2021 Jul-Aug; 42(4):103037.
    View in: PubMed
    Score: 0.235
  54. Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms. Acta Otolaryngol. 2021 Jun; 141(6):615-620.
    View in: PubMed
    Score: 0.234
  55. Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients. Pathogens. 2021 Jan 12; 10(1).
    View in: PubMed
    Score: 0.231
  56. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. 2021 Jan; 146:110406.
    View in: PubMed
    Score: 0.229
  57. COVID-19 Reinfection and Second Episodes of Olfactory and Gustatory Dysfunctions: Report of First Cases. Ear Nose Throat J. 2020 Nov 10; 145561320970105.
    View in: PubMed
    Score: 0.228
  58. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered. Eur Arch Otorhinolaryngol. 2021 Jul; 278(7):2187-2191.
    View in: PubMed
    Score: 0.225
  59. ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology (Basel). 2020 Aug 18; 9(8).
    View in: PubMed
    Score: 0.225
  60. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020 11; 27(11):2318-2321.
    View in: PubMed
    Score: 0.224
  61. Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak. Virol Sin. 2020 12; 35(6):833-837.
    View in: PubMed
    Score: 0.224
  62. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020 09; 288(3):335-344.
    View in: PubMed
    Score: 0.222
  63. Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients. Am J Otolaryngol. 2020 Sep - Oct; 41(5):102605.
    View in: PubMed
    Score: 0.221
  64. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020. Emerg Infect Dis. 2020 Sep; 26(9).
    View in: PubMed
    Score: 0.221
  65. [The alteration of smell and taste in COVID-19 patients. A diagnostic resource in primary care]. Aten Primaria. 2020 10; 52(8):592-593.
    View in: PubMed
    Score: 0.221
  66. Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations. New Microbes New Infect. 2020 Jul; 36:100696.
    View in: PubMed
    Score: 0.221
  67. Are the Acoustic Measurements Reliable in the Assessment of Voice Quality? A Methodological Prospective Study. J Voice. 2021 Mar; 35(2):203-215.
    View in: PubMed
    Score: 0.211
  68. An unusual cause of obstructive sleep apnea syndrome. Clin Case Rep. 2019 Sep; 7(9):1694-1696.
    View in: PubMed
    Score: 0.209
  69. Surgical Treatment for Laryngopharyngeal Reflux Disease: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 07 01; 145(7):655-666.
    View in: PubMed
    Score: 0.208
  70. Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019 Feb 15; 11(2).
    View in: PubMed
    Score: 0.202
  71. In Reference to Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux. Laryngoscope. 2019 04; 129(4):E118-E119.
    View in: PubMed
    Score: 0.201
  72. Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. J Clin Med. 2019 Jan 10; 8(1).
    View in: PubMed
    Score: 0.201
  73. Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis. Laryngoscope. 2019 05; 129(5):1174-1187.
    View in: PubMed
    Score: 0.200
  74. Laryngopharyngeal reflux disease: clinical presentation, diagnosis and therapeutic challenges in 2018. Curr Opin Otolaryngol Head Neck Surg. 2018 Dec; 26(6):392-402.
    View in: PubMed
    Score: 0.199
  75. High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus. Oncotarget. 2018 Feb 16; 9(13):11046-11059.
    View in: PubMed
    Score: 0.188
  76. Hibernoma: a rare case of adipocytic tumor in head and neck. BMC Ear Nose Throat Disord. 2017; 17:13.
    View in: PubMed
    Score: 0.187
  77. Laryngopharyngeal Reflux and Voice Disorders: A Multifactorial Model of Etiology and Pathophysiology. J Voice. 2017 Nov; 31(6):733-752.
    View in: PubMed
    Score: 0.178
  78. High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Oral Oncol. 2017 04; 67:183-191.
    View in: PubMed
    Score: 0.178
  79. Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction. Indian J Otolaryngol Head Neck Surg. 2021 Aug 22; 1-2.
    View in: PubMed
    Score: 0.060
  80. Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients. Laryngoscope. 2021 10; 131(10):2312-2318.
    View in: PubMed
    Score: 0.060
  81. Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients. Int Forum Allergy Rhinol. 2022 01; 12(1):103-107.
    View in: PubMed
    Score: 0.060
  82. Correction to: Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position. Eur Arch Otorhinolaryngol. 2021 Jul; 278(7):2661.
    View in: PubMed
    Score: 0.060
  83. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J Laryngol Otol. 2021 Aug; 135(8):723-728.
    View in: PubMed
    Score: 0.060
  84. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol. 2022 Feb; 279(2):811-816.
    View in: PubMed
    Score: 0.059
  85. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study. J Laryngol Otol. 2021 May; 135(5):436-441.
    View in: PubMed
    Score: 0.059
  86. Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021 Feb 01; 59(1):21-25.
    View in: PubMed
    Score: 0.058
  87. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2021 Feb 01; 59(1):26-31.
    View in: PubMed
    Score: 0.058
  88. Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain. Med Clin (Engl Ed). 2021 Jan 22; 156(2):61-64.
    View in: PubMed
    Score: 0.057
  89. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020 Dec; 134(12):1123-1127.
    View in: PubMed
    Score: 0.057
  90. Predictive Accuracy of COVID-19 World Health Organization (WHO) Severity Classification and Comparison with a Bayesian-Method-Based Severity Score (EPI-SCORE). Pathogens. 2020 Oct 24; 9(11).
    View in: PubMed
    Score: 0.057
  91. Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19. Indian J Otolaryngol Head Neck Surg. 2020 Sep 30; 1-3.
    View in: PubMed
    Score: 0.057
  92. [Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain]. Med Clin (Barc). 2021 01 22; 156(2):61-64.
    View in: PubMed
    Score: 0.057
  93. Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2. Ear Nose Throat J. 2021 Apr; 100(2_suppl):188S-191S.
    View in: PubMed
    Score: 0.056
  94. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug; 134(8):703-709.
    View in: PubMed
    Score: 0.056
  95. Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020 Aug 06; 49(1):56.
    View in: PubMed
    Score: 0.056
  96. A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study. J Med Virol. 2021 02; 93(2):983-994.
    View in: PubMed
    Score: 0.056
  97. Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study. J Infect. 2020 11; 81(5):816-846.
    View in: PubMed
    Score: 0.056
  98. Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol. 2020 Jul; 134(7):571-576.
    View in: PubMed
    Score: 0.056
  99. Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position. Eur Arch Otorhinolaryngol. 2021 Jun; 278(6):1733-1742.
    View in: PubMed
    Score: 0.056
  100. MRI of Patients Infected With COVID-19 Revealed Cervical Lymphadenopathy. Ear Nose Throat J. 2021 Jan; 100(1):26-28.
    View in: PubMed
    Score: 0.056
  101. Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients. Eur Arch Otorhinolaryngol. 2020 Oct; 277(10):2783-2792.
    View in: PubMed
    Score: 0.056
  102. Systematic review of international guidelines for tracheostomy in COVID-19 patients. Oral Oncol. 2020 09; 108:104844.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.